enalapril and Infant--Premature--Diseases

enalapril has been researched along with Infant--Premature--Diseases* in 1 studies

Other Studies

1 other study(ies) available for enalapril and Infant--Premature--Diseases

Article	Year
Use of enalapril in neonatal hypertension. Acta paediatrica (Oslo, Norway : 1992), 1995, Volume: 84, Issue:12 Treatment of hypertension with enalapril in a preterm infant is described. Enalapril is a new converting enzyme blocker with a longer plasma half-life and less side effects than captopril. Oral administration of enalapril 0.1 mg/kg caused severe hypotension and renal failure in a preterm infant. We recommend an oral starting dose of 0.01 mg/kg in preterm infants and extremely close monitoring of infants receiving the first dose of enalapril. Topics: Acute Kidney Injury; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enalapril; Humans; Hypotension; Infant, Newborn; Infant, Premature, Diseases; Male	1995

Article

Year

Use of enalapril in neonatal hypertension.

Acta paediatrica (Oslo, Norway : 1992), 1995, Volume: 84, Issue:12

Treatment of hypertension with enalapril in a preterm infant is described. Enalapril is a new converting enzyme blocker with a longer plasma half-life and less side effects than captopril. Oral administration of enalapril 0.1 mg/kg caused severe hypotension and renal failure in a preterm infant. We recommend an oral starting dose of 0.01 mg/kg in preterm infants and extremely close monitoring of infants receiving the first dose of enalapril.

Topics: Acute Kidney Injury; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enalapril; Humans; Hypotension; Infant, Newborn; Infant, Premature, Diseases; Male

1995